IGF2BP3 is highly expressed in a variety of tumors including HCC, lung, and prostate cancers, and it helps maintain tumor cell growth, proliferation, invasion, and drug resistance through several oncogenic pathways [51]. This evidence concerns the gene IGF2BP3 and prostate carcinoma.